Outpace Bio raises $30m led by Artis Ventures, Lyell

The Seattle-based company raises funding from in an oversubscribed round led by Artis Ventures and Lyell Immunopharma.

1 April 2021•1 min read
LinkedInXEmail
LinkedInXEmail

Related articles